The effect of aerosol challenge of rhesus macaques with Bordetella pertussis and the feasibility 34 of using rhesus monkeys as an animal model for pertussis infection were evaluated in this study. 35
Introduction 52
Pertussis is a contagious respiratory disease caused by the bacterium Bordetella pertussis. 53
The disease is characterized by sudden spasmodic cough accompanied by inspiratory whoop or 54 posttussive emesis lasting several months and may cause death in infants without treatment [1] . 55 Guillaume De Baillou first described a pertussis outbreak in Paris in the summer of 1578 [2] . The 56 epidemic involved mainly infants, and the mortality rate was high. The diagnosis of pertussis was 57 based primarily on bacterial culture [3, 4] , antigen detection by polymerase chain reaction [5] , and 58 serological antibody detection [6] . Pertussis remains a major threat to the health of children 59 worldwide and causes high economic burden at the state and local level [7, 8] . 11]. The vaccine significantly reduced the incidence of pertussis. However, in recent years, the 64 effectiveness of pertussis vaccine has been contested. In the United States, although the pertussis 65 vaccination rate is >95%, the incidence of pertussis in the past 30 years is increasing [12] , 66 especially in 2004, 2010, and 2012[13, 14] . This increase may be related to the decrease in the 67 immune protective efficiency induced by vaccination [15] , transmission of asymptomatic latent 68 infection [16] , cross-infection via healthcare personnel and travelers [17, 18] , and pathogen 69 adaptation in immune populations after large-scale vaccination [19] . 70
The immune mechanisms underlying pertussis infection and the efficacy of new vaccines and 71 combined vaccines can be studied by establishing suitable animal models that replicate the full 72 spectrum of the disease. Most infection studies are carried out in mouse, rat, rabbit, and piglet 73 models of pertussis [20, 21] . However, these models cannot reproduce the full clinical spectrum 74 achieved in human models [22, 23] . With respect to studies using non-human primate models, a 75 successful baboon model was established by Warfel et al [24] . However, the use of baboons as an 76 animal model of pertussis is limited because of the limited availability of animals, high housing 77 costs, and lack of suitable reagents. Compared with the baboon model, the advantages of using 78 rhesus macaque models include high availability of animals, low housing costs, and availability of 79 suitable reagents, and therefore this animal model is considered ideal [25] . Since 1929, three 80 studies have evaluated the infection of rhesus monkeys with B. pertussis. However, these studies 81
could not replicate the clinical disease in humans [26] [27] [28] . 82
In the present study, rhesus macaques aged 12 to 14 months were challenged with B. 83 pertussis via aerosol injection; indices of infection, including leukocyte count and colonization ofthe nasopharynx, were determined; and the humoral immune response and cytokines were 85 analyzed to assess the possibility of using rhesus monkeys as an animal model for pertussis 86 infection. Infection efficiency was evaluated after challenge for different periods. saline and transferred to a flask containing culture medium. The medium was incubated in an 98 incubator at 37 °C and transferred to two flasks containing culture medium. After incubation at 99 37 °C for 48 h, the medium was transferred to four to six flasks and incubated at 37 °C for 24 h. 100
The bacterial sediment was resuspended in isotonic saline, diluted to a concentration of 10 11 101 CFU/mL using a turbidimetric method, and used within 2 h after preparation. were assigned to two groups randomly, with two animals in each group (one male and one female). 107
Animal study was conducted in compliance with the Animal Welfare Act, Declaration of Helsinki 108 (2013 revision) and other regulations relating to animal experiments. The rhesus macaques were 109 confirmed to be healthy, acclimated to the animal house, and identified by hanging tag on the neck. 110
And these animals were fed with food and fruits strictly complying with requirements of animal 111 welfare and music was played during 11:00 ~13:00 every day. 112 113
1.3 Challenge of rhesus macaques The aerosol apparatus used for this study was designed by our 114 lab and produced by Lanfang Honlan Equipment Co. The apparatus was composed of a 115 rectangular Plexiglas chamber with a removable lid (40 cm × 60 cm × 40 cm) , a pump and a 116 medical nebulizer (average atomization rate:  0.15 mL/min, working pressure: 60-150 KPa, 117 normal working condition: 10-40 °C). The pump was connected to the inlet side of the nebulizer 118 to deliver B. pertussis suspension for atomization. The outlet side of the nebulizer was connected 119 to two inlet port of the challenge chamber to deliver atomized B. pertussis to the interior of the 120 chamber. Outlet tube with an air filter was connected to the challenge chamber to remove air. An 121 air sampling port was embedded in the middle of the challenge chamber to monitor actual 122 concentration of aerosol B. pertussis inside the chamber (Fig 1) . B. pertussis strain 18323 at a concentration of 10 11 CFU/mL with 8mL was delivered to the 127 nebulizer for aerosolisation. After aerosol generation, 10 mL of air was sucked out from the 128 sampling port every 5 min using syringes and injected into 10 mL saline. The solution was 129 transferred to B-G medium and the number of colonies was determined to ensure actual challenge 130 concentration.
131
The rhesus macaques of one group were placed into the challenge box for challenging. In group 1, 132 the macaques were numbered as 1 and 2, and were challenged with 10 5 CFU/mL for 30 min. In 133 group 2, the macaques were numbered as 3 and 4 and were challenged with 10 5 CFU/mL for 60 134 min. After challenging, the two groups were housed separately. 135 136
Monitoring the rectal temperature of rhesus macaques
The rectal temperature in the two 137 groups was measured before aerosol challenge and at days 3, 5, 7, 10, 14, 21, 31, and 45 after 138 challenge. 139 140 1.5 White blood cell (WBC) count A volume of 150 µL of EDTA-anticoagulated venous blood 141 was drawn before aerosol challenge and at days 3, 5, 7, 10, 14, 21, 31, and 45 after challenge. The 142 number of WBCs was determined by blood cell counting. 143 144
1.6 Culture of nasopharyngeal bacteria At each sampling point, nasopharyngeal bacteria were 145 collected using nasopharyngeal and nasal swabs. Bacteria were suspended in 1 mL of saline and 146 cultured in B-G medium containing 30% sterile defibrinated sheep blood diluted 100, 400, 800, 147 and 1600-fold within 2 h. The number of colonies was determined after 5 days. Colonies were 148 picked from the blood agar, subjected to Gram staining, and their morphology was analyzed by 149 microscopy. Bacterial DNA was extracted and identified by 16S rRNA sequencing. Sequencing 150 was performed by Beijing Nuohezhiyuan Technology CO., Ltd. in an Illumina technology 151 sequencing platform using the paired-end method. 152 153
1.7 Determination of antibodies of rhesus macaques after challenge The venous blood of the 154 two animal groups was drawn before aerosol challenge and at days 7, 10, 14, 21, 31, 45, and 60 155 after challenge. Serum was separated and anti-PT, PRN, FHA antibody titers were measured using 156 ELISA. A 96-well microplate was coated with 3 μg/mL of antigens PT, PRN, and FHA and 157 incubated at 4 °C overnight. Diluted serum was added to the microplate and incubated at 37 °C for 158 1 h（All the antigens are come from Department of DTP Vaccine and Toxin, National Institute for 159
Food and Drug Control, China）. After that, HRP-labeled sheep anti-monkey IgG was added to the 160 microplate, and the plate was incubated at 37 °C for 1 h. The substrate 3, 3, 5, 5 161 tetramethylbenzidine (TMB) was added to the microplate, the plate was incubated at room 162 temperature for 30 min, and the reaction was terminated by adding H 2 SO 4 5 CFU/mL 10 min after challenge, and this level was maintained until the 188 end of the study period (Fig. 2) . coughing gradually disappeared after 21 days. However, as lack of suitable video recording 199 system, coughing frequency and duration were not recorded. After challenge for 3 days, the 200 rectal temperature of both groups was increased, peaked at days 5 and 7, and returned to normal 201 levels at day 21 after challenge (Fig. 3A) . 202
The number of WBCs in the two study groups was significantly increased at day 3 after challenge 203 (P<0.05) and reach to the highest level at day 7 and returned to baseline values at day 45 (Fig. 3B) . 6 /mL (P<0.05) in groups 1 and 2, respectively. After 21 days, the number of colonies 221 was decreased significantly (Fig. 4) . 222
For bacterial identification, colonies collected from nasopharyngeal swabs (P1.5d, P2.5d, P3.5d, 223 P4.5d) and nasal swabs (N1.5d, N2.5d, N3.5d, N4.5d) at day 5 after challenge and grown on 224
Bordet-Gengou agar and B. pertussis grown on Bordet-Gengou agar were selected and identified 225 by 16s rRNA sequencing. The results demonstrated that the sequences of colonies identified in 226 nasopharyngeal swabs at day 5 after challenge were highly homologous to those of B. pertussis 227 (35-95% as B. pertussis). In turn, the sequences of bacterial colonies identified in nasal swab 228 samples at day 5 after challenge presented little homology to those of B. pertussis (the degree ofhomology to B. pertussis in one macaque was 25%). The bacteria were identified as Firmicutes 230 and Actinobacteria, but not Proteobacteria. These results indicated that B. pertussis was present 231 primarily in the nasopharyngeal (Fig. 5) . 232 233
Fig. 4 Colonization of nasopharynx of rhesus macaques after challenged with atomized B. 234
Pertussis At each sampling point, nasopharyngeal bacteria was taken using nasal and nasopharynx 235 swabs, and suspended in 1mL saline. Similar as method described in Fig 2, 100μL was spread on 236 cell culture, incubated at 37℃ for 4 days and number of colonies was determined, *p＜0.05，**p 237 ＜0.01. 
Aerosol challenge induced specific antibody responses against B. pertussis Anti-PT, PRN, 246
FHA antibody titers were measured after challenge with B. pertussis. The seroconversion rate of 247 antibody against PT reached 100% at day 14, and the seroconversion rate of antibody against FHA 248 reached 100% at day 7 in both groups, the seroconversion rate of antibody against PRN reached 249 100% at day 7 and day 10 for group 1 and group 2, respectively. In group 1, the antibody level 250 against PT, and FHA peaked after day 31 with GMTs of 4.41， 4.81, respectively, the antibody level 251 against PRN peaked after day 14 with GMTs of 4.35, and declined afterward (Fig. 6A) . In group 2, 252 the antibodies induced by pertussis were significantly elevated, and the GMTs of the antibodies 253 against PT, FHA, and PRN, were 4.81, 4.96, and 5.31, respectively. The titers tended to of decline,as in group 1 (Fig. 6B) . results indicated that IL-10 and IL-6 in the serum at day 5 after challenge were significantly 266 increased in group 1 (P<0.05) (Fig. 7) . In group 2, IL-8 increased significantly at day 5 267 post-challenge, IL-6 increased significantly at day 7 post-challenge (P<0.05), and IL-2, IL-17A, 268 IL-12 (p40), and IL-18 significantly increased at day 14 and decreased at day 21 post-challenge. 269 (P<0.05) (Fig. 8) . IL-10 increased significantly from day 14 to day 21, and decreased at day 31. 270 IL-13 increased from day 10 and reached the highest at day 14, then decrease but still significant 271 hither than pre-post, finally decreased at day 31. significantly increased at day 3, peaked at day 7, and decreased gradually after that, and returned 310 to baseline levels at day 45. The post-challenge concentration of WBCs was 6-fold higher than the 311 baseline level. Second, the number of colonies in nasopharyngeal swabs peaked at day 14 after 312 challenge, reached 10 6.73-6.91 per mL and returned to baseline levels after 31 days. Bacterial 313 sequencing indicated that colonies were present only in nasopharyngeal samples but not in nasal 314 samples. Third, the rectal temperature of rhesus macaques was increased at days 3 to 7 after 315 challenge, and coughing was observed. However, lacking of suitable video recording system, the 316 coughing frequency and duration were not recorded in present study. In the following research, 317 these should be investigated in detail to provide the further information. 318
Another critical factor to consider when establishing an animal model is the age of the animals. 319
A previous study using an enterovirus type 71 (EV71) rhesus monkey model suggested that, of the 320 challenged animals, a clinical spectrum similar to that of humans was observed only in young 321 animals [35] . Previous studies that challenged rhesus monkeys with pertussis investigated the 322 fold-change in WBC counts and cough but did not evaluate clinical signs at adults animal [26, 28] . 323
Huang et al [36] has changed Taiwan monkey (Macaca cyclopsis) using 18-323 of H. pertussis and 324 have investigated that the whooping cough, dynamic changes in leukocytosis and antibody 325 response but not fever at young monkey. However it just mentioned the weighing of monkeys was 326 from 550 to 1875 gm, but not the age information be recorded. A study that used baboons as a 327 successful non-human primate pertussis model reported that young baboons showed severedisease signs whereas adult baboons showed mild signs [31] . In the present study, rhesus monkeys 329 aged 12 to 14 months were selected. In our study, the body temperature of rhesus macaques after 330 challenge was increased 1～1.5 °C, which is similar to the increase observed in baboons infected 331 with B. pertussis by the endotracheal route [24] . In the baboon model, the peak WBC count was 332 5～10-fold higher than baseline counts in nine baboons. In our study, the peak WBC count was 333 4.5～8.4-fold higher than the baseline count. B. pertussis was found in nasopharyngeal samples of 334 rhesus macaque. In addition, the bacterial count reached 8.1 × 10 6 /mL and was gradually 335 decreased, which is similar to the results obtained using the baboon model. Therefore, we deduced 336 that the change route as well as the age of the animals may influence the infection of B pertussis. The WBC count, number of colonies in nasopharyngeal samples, and anti-PT, PRN, and FHA 355 antibody titers were significantly higher in group 2 compared to group 1. The levels of IL-10 and 356 IL-6 in group 1 were significantly increased after challenge whereas more cytokines were 357 increased in group 2, indicating that group 2 produced stronger cellular and humoral immune 358 responses and presented more obvious symptoms compared to group 1. These observations could 359 be relevant to high infection doses. The Th1, Th2, and Th17 responses observed in group 2 were 360 similar to those found in the baboon model. Our results demonstrated that aerosol-challenged 361 rhesus macaques aged 12 months could serve as an animal model of pertussis, and a bacterial 362 concentration of 10 5 CFU/mL for 60 min was a suitable challenge intervention. 363
The type of challenge bacteria is another critical factor of study of animal model for pertussis. 364
The baboon animal model conducted by Warfel et al [24] used B. pertussis strain D420, a recent 365 clinical isolate from human infant with severe respiratory distress. In present study, 366 CMCC58030(18323), which identified by Pearl Kendrick in the 1940s [42] was used. This stains 367 also been used to challenge Taiwan Monkey in Huang et al's study and showed the experimental 368 whooping cough sighs. The recent analysis on global population structure of B. pertussis has 369
suggested that the prevalence of B. pertussis has changed in the last 100 years worldwide, in 370 which strain 18323 belongs to the branch contains of a small number of stains showing a long 371 distance from the major prevalent branch [43] . However strain 18323 is still used for determinationof potency for vaccines in China [44] . Surely, the prevalent stain isolated recently could provide a 373 more powerful information, and it should be used to monitor pathogenicity difference of animal 374 response in the future study. 375
In summary, the characteristic of pertussis infection in infant rhesus macaque was similar as in 376 human beings, which provide a clue to using infant rhesus macaque as a candidate model of 377 pertussis infection in the future studies for analyzing pertussis infection mechanisms and pertussis 378 vaccines. 379 380 381
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